Skip to content
Open access

Left atrial remodeling parallels ventricular damage and predicts atrial fibrillation in chagas cardiomyopathy

Oct 2026 · European Heart Journal · 0 citations

Abstract

Atrial cardiomyopathy is a frequent complication of Chagas disease, driven by chronic inflammation and fibrosis. We hypothesized that left atrial (LA) remodeling progresses in parallel with left ventricular (LV) damage and predicts new-onset atrial fibrillation (AF). We studied 50 patients with chronic Chagas cardiomyopathy (age 51±9 years, 70% female), all in sinus rhythm at baseline, followed at a tertiary center (mean 83.5±40.7 months). New-onset AF was assessed by serial Holter and ECG. LA anteroposterior diameter, LV mass (Devereux), and LVEF (Teichholz) were obtained by echocardiography from the parasternal long-axis view at admission and follow-up. Paired echocardiograms were available in 34 patients. LA enlargement was defined as diameter >4.0 cm. At baseline, 37 patients (74%) had normal LA diameter. AF incidence was 2.55/100 person-years (95%CI 1.17–4.85) and new LA enlargement 1.73/100 person-years (95%CI 0.56–4.03); 9 patients died. LA diameter increased at 0.6±1.4 mm/year (p<0.001) and LV mass at 6.9±23.6 g/year (p=0.027). Over follow-up, LA diameter increased from 3.55±0.62 cm to 3.90±0.58 cm (p<0.001), LV mass from 153.8±51.7 g to 206.9±73.0 g (p<0.001), and LVEF declined from 69.3±16.3 % to 61.0±18.9% (p<0.001) (Figure 1). Patients who developed AF had larger baseline LA (4.0±0.6 vs 3.5±0.6 cm; p=0.019); and baseline LA > 4.0 cm predicted AF (OR=5.16; p=0.040). Non-survivors had LA larger at admission (4.0±0.7 vs 3.5±0.5 cm; p=0.031) and at follow-up (4.7±0.7 vs 3.8±0.4 cm; p=0.005). The annual rate of LA enlargement strongly correlated with LV mass increase (r=0.84, p<0.001). In Chagas cardiomyopathy, progressive LA enlargement mirrors LV remodeling, and predicts new-onset AF, suggesting that atrial cardiomyopathy is not an isolated event but part of a global fibrotic process. Serial LA assessment may identify patients at higher risk of AF and death.Atrial and ventricular remodeling

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.